Interobserver reproducibility of cytologic p16INK4a/Ki-67 dual immunostaining in human papillomavirus-positive women-Reference-Cited by-同舟云学术

Interobserver reproducibility of cytologic p16INK4a/Ki-67 dual immunostaining in human papillomavirus-positive women

Published:2016-12-07 Issue:3 Volume:125 Page:212-220
ISSN:1934-662X
Container-title:Cancer Cytopathology
language:en
Short-container-title:Cancer Cytopathology

Author:

Benevolo Maria¹,Allia Elena²^ORCID,Gustinucci Daniela³,Rollo Francesca¹,Bulletti Simonetta³,Cesarini Elena³,Passamonti Basilio³,Giovagnoli Maria Rosaria⁴,Carico Elisabetta⁴,Carozzi Francesca M.⁵,Mongia Alessandra⁵,Fantacci Giulia⁵,Confortini Massimo⁵,Rubino Teresa⁶,Fodero Cristina⁶,Prandi Sonia⁶,Marchi Natalina⁷,Farruggio Angelo⁷,Coccia Anna²,Macrì Luigia²,Ghiringhello Bruno²,Ronco Guglielmo²,Bragantini Emma⁸,Polla Enzo⁸,Maccallini Vincenzo⁹,Negri Giovanni¹⁰,Giorgi Rossi Paolo⁶¹¹,

Affiliation:

1. Regina Elena National Cancer Institute; Rome Italy

2. Central Cervicovaginal Screening Unit and Center for Cancer Epidemiology and Prevention; Turin Italy

3. Laboratory Screening Unit, Local Health Authority-Umbria 1; Perugia Italy

4. Cytopathology Unit, St Andrea Hospital, “Sapienza” University; Rome Italy

5. Human Papillomavirus Laboratory and Molecular Oncology Unit, Regional Cancer Prevention Laboratory, Institute for Cancer Study and Prevention; Florence Italy

6. Institute for Research and Health Care (IRCCS), “Arcispedale S. Maria Nuova” Hospital; Reggio Emilia Italy

7. Unit 17, Local Health and Social Care Facility; Este Monselice Italy

8. Provincial Health Care Service; Trento Italy

9. Department of Pathology, Avezzano, Sulmona, and L'Aquila Local Health Trust-Abruzzo; Avezzano Italy

10. Department of Pathology; Bolzano Central Hospital; Bolzano Italy

11. Interinstitutional Epidemiology Unit, Reggio Emilia Local Health Trust; Reggio Emilia Italy

Funder

New Technologies for Cervical Cancer Screening 2 (NTCC2) trial funded by the Italian Ministry of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference33 articles.

1. Efficacy of HPV-based Screening for Preventing Invasive Cervical Cancer: follow-up of European randomised controlled trials;Ronco;Lancet,2014

2. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer;Saslow;Am J Clin Pathol,2012

3. Screening for cervical cancer: US Preventive Services Task Force recommendation statement;Moyer;Ann Intern Med.,2012

4. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections;Knebel Doeberitz;Eur J Cancer,2002

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary Human Papillomavirus Testing and Other New Technologies for Cervical Cancer Screening;Obstetrics & Gynecology;2023-09-13

2. Evaluation of the clinical performance of p16/Ki-67 dual-staining cytology for cervical lesion detection in premenopausal and postmenopausal Chinese women;Journal of Cancer Research and Clinical Oncology;2023-06-11

3. Reproducibility of cytological diagnoses in evaluating liquid cervical smears and immunocytochemical co-expression of p16/Ki-67 using manual and automatic methods;Gynecology;2023-01-20

4. HPV-associated cervicitis;Gynecology;2023-01-20

5. Cervical screening strategies: a modern perspective;Rossiiskii vestnik akushera-ginekologa;2023